Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001587221-20-000026
Filing Date
2020-08-06
Accepted
2020-08-06 09:01:51
Documents
65
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q zsan-20200630.htm   iXBRL 10-Q 2025372
2 EX-10.1 q2exhibit101formofiso.htm EX-10.1 26536
3 EX-10.2 q2exhibit102formofnq.htm EX-10.2 22215
4 EX-10.3 q2exhibit103rsu.htm EX-10.3 71400
5 EX-31.1 q2exhibit311ng.htm EX-31.1 11284
6 EX-31.2 q2exhibit312ng.htm EX-31.2 11405
7 EX-32.1 q2exhibit321ng.htm EX-32.1 12096
  Complete submission text file 0001587221-20-000026.txt   8197620

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT zsan-20200630.xsd EX-101.SCH 49229
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT zsan-20200630_cal.xml EX-101.CAL 95521
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT zsan-20200630_def.xml EX-101.DEF 222930
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT zsan-20200630_lab.xml EX-101.LAB 566501
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT zsan-20200630_pre.xml EX-101.PRE 355376
13 EXTRACTED XBRL INSTANCE DOCUMENT zsan-20200630_htm.xml XML 1540342
Mailing Address 34790 ARDENTECH COURT FREMONT CA 94555
Business Address 34790 ARDENTECH COURT FREMONT CA 94555 510-745-1200
Zosano Pharma Corp (Filer) CIK: 0001587221 (see all company filings)

EIN.: 454488360 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36570 | Film No.: 201080143
SIC: 2834 Pharmaceutical Preparations